Prostate Cancer clinical trials
Showing 601–650 of 735 active trials. Describe your situation to see which ones you may be eligible for.
- A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Distance-Based Exercise to Preserve Function and Prevent Disability
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
- Comprehensive Outcomes for After Cancer Health
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Video Education With Result Dependent dIsclosure
- Access to Genetic Testing in Underserved Patients With Cancer
- Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Addressing Genomic Disparities in Cancer Survivors
- Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
- Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
- Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
- Serial MRI Scans During Radiation Therapy
- Better Options for Chronic Cancer Pain
- Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery
- WATER IV PCa (AS Sub-study)
- Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
- Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer
- Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
- dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy
- Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
- Whole Versus Partial Gland Boost During Prostate SBRT
- PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
- Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
- Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
- Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
- A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
- Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
- Folate Study in Men With Advanced Prostate Cancer
- Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
- A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
- Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
- Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation
- Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
- PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy
- Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
- Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
- ExosomeDx in MRI-negative Men With High PSA
- Preoperative Semaglutide Prior to Radical Prostatectomy
- Phase IIb Trial to Investigate the Safety and Efficacy of OTL78 Injection (Zopocianine)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.